How IVF became a licence to print money
By Fay Schopen,
The Guardian
| 06. 18. 2018
I don’t consider myself to be lucky. I have never won the lottery, or even found a fiver in an old coat pocket. But there is one aspect in life where fortune has smiled on me: I am eight months pregnant with my first child – the result of IVF treatment.
Around three-quarters of all IVF cycles fail. And results vary with age. Figures from the Human Fertilisation and Embryology Authority (HFEA) published in March state the average live birthrate for each fresh embryo transferred for women of all ages is 21%; for those aged under 35, it is 29% – the highest it has ever been. For older women, the picture is bleaker: 10% for women aged 40-42, for example.
In 2011, then aged 36, I underwent one cycle of IVF, funded by my local NHS trust, before I was treated for breast cancer. The embryos were frozen and in 2016 I embarked on the next stage: implantation. Funding was unavailable because I was by then over 40 and it was clear to me that IVF funding was unfair...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
